Hillrom and Welch Allyn are a part of Baxter.
text.skipToContent text.skipToNavigation
  1. Baxter Catalog
  2. Pharmaceuticals
  3. Vials & Other Injectables
  4. NEXTERONE (amiodarone HCI) Premixed Injection 360 mg/200 mL in GALAXY Plastic Container. Liquid Premix.
Due to missing information on your Hillrom Direct account, you are not able to add items to the cart or continue with the checkout process. Please contact our customer support team for further assistance by clicking on "contact us".
MP_logo
NEXTERONE (amiodarone HCI) Premixed Injection 360 mg/200 mL in GALAXY Plastic Container. Liquid Premix.
Item Number: 2G3450
GTIN:  0343066360207
GTIN-CS:  10343066360204
Nexterone (amiodarone HCI, USP) Premixed Injection 360 mg/200 mL (1.8 mg/mL) in GALAXY Container. Liquid Premix. Single Dose Ready- to-use, sterile, nonpyrogenic, iso-osmotic solution (in Dextrose). NDC 43066-360-20
Specifications

Product Characteristics

Volume 200.0 ml
DEHP Free No
PVC Free No
Latex Free No
Shelf Life from Manufacture 0
Concentration 1.8 mg/mL
Container Type GALAXY
Containes Preservative No
Diluent Dextrose
Dosage Form Liquide
Drug Class Anti-Arrythmics
Rx Only Yes
Storage Recommendations Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F). See USP Controlled Room Temperature. Protect from light and excessive heat. Protect from freezing.
Strength 360 mg/200 mL

Carton

Units per Case 10.0
Carton Weight 6.5 lb.
Carton Length 12.0 in.
Carton Width 6.2 in.
Carton Height 3.0 in.
Carton Volume 223.2 ci

Reimbursement Information

HCPCS Code HCPCS Description
J0283 "INJECTION, AMIODARONE HCI, 30 MG"
A4216 "STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML"
Medication Delivery Reimbursement Hotline 888-338-0001

Information Source : CMS

Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Ordering Information
Item Number 2G3450
Sales Unit case
GTIN 0343066360207
GTIN-CS 10343066360204
National Drug Code 43066036020